Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Metagenomics is the study of genetic material recovered directly from environmental samples.
The global Metagenomics market size is expected to reach US$ 397.8 million by 2029, growing at a CAGR of 9.5% from 2023 to 2029. The market is mainly driven by the significant applications of Metagenomics in various end use industries.
The expanding demands from the Infectious Disease Diagnosis, Environmental Remediation and Others,, are propelling Metagenomics market. Sequencing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bioinformatics segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Metagenomics market, driven by demand from China, the second largest economy with some signs of stabilising, the Metagenomics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metagenomics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metagenomics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metagenomics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metagenomics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metagenomics covered in this report include F. Hoffmann-La Roche, PerkinElmer, Thermo Fisher Scientific, The MITRE Corporation, Quest Diagnostics, Agilent Technologies, Aperiomics, Promega and Oxford Nanopore, etc.
The global Metagenomics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Metagenomics market, by region:
Global Metagenomics market, Segment by Type:
Global Metagenomics market, by Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metagenomics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Metagenomics
1.1 Metagenomics Market Overview
1.1.1 Metagenomics Product Scope
1.1.2 Metagenomics Market Status and Outlook
1.2 Global Metagenomics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metagenomics Market Size by Region (2018-2029)
1.4 Global Metagenomics Historic Market Size by Region (2018-2023)
1.5 Global Metagenomics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metagenomics Market Size (2018-2029)
1.6.1 North America Metagenomics Market Size (2018-2029)
1.6.2 Europe Metagenomics Market Size (2018-2029)
1.6.3 Asia-Pacific Metagenomics Market Size (2018-2029)
1.6.4 Latin America Metagenomics Market Size (2018-2029)
1.6.5 Middle East & Africa Metagenomics Market Size (2018-2029)
2 Metagenomics Market by Type
2.1 Introduction
2.1.1 Sequencing
2.1.2 Bioinformatics
2.2 Global Metagenomics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metagenomics Historic Market Size by Type (2018-2023)
2.2.2 Global Metagenomics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metagenomics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metagenomics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metagenomics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metagenomics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metagenomics Revenue Breakdown by Type (2018-2029)
3 Metagenomics Market Overview by Application
3.1 Introduction
3.1.1 Infectious Disease Diagnosis
3.1.2 Environmental Remediation
3.1.3 Others
3.2 Global Metagenomics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metagenomics Historic Market Size by Application (2018-2023)
3.2.2 Global Metagenomics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metagenomics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metagenomics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metagenomics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metagenomics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metagenomics Revenue Breakdown by Application (2018-2029)
4 Metagenomics Competition Analysis by Players
4.1 Global Metagenomics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metagenomics as of 2022)
4.3 Date of Key Players Enter into Metagenomics Market
4.4 Global Top Players Metagenomics Headquarters and Area Served
4.5 Key Players Metagenomics Product Solution and Service
4.6 Competitive Status
4.6.1 Metagenomics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche
5.1.1 F. Hoffmann-La Roche Profile
5.1.2 F. Hoffmann-La Roche Main Business
5.1.3 F. Hoffmann-La Roche Metagenomics Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Metagenomics Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Recent Developments
5.2 PerkinElmer
5.2.1 PerkinElmer Profile
5.2.2 PerkinElmer Main Business
5.2.3 PerkinElmer Metagenomics Products, Services and Solutions
5.2.4 PerkinElmer Metagenomics Revenue (US$ Million) & (2018-2023)
5.2.5 PerkinElmer Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Metagenomics Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Metagenomics Revenue (US$ Million) & (2018-2023)
5.3.5 The MITRE Corporation Recent Developments
5.4 The MITRE Corporation
5.4.1 The MITRE Corporation Profile
5.4.2 The MITRE Corporation Main Business
5.4.3 The MITRE Corporation Metagenomics Products, Services and Solutions
5.4.4 The MITRE Corporation Metagenomics Revenue (US$ Million) & (2018-2023)
5.4.5 The MITRE Corporation Recent Developments
5.5 Quest Diagnostics
5.5.1 Quest Diagnostics Profile
5.5.2 Quest Diagnostics Main Business
5.5.3 Quest Diagnostics Metagenomics Products, Services and Solutions
5.5.4 Quest Diagnostics Metagenomics Revenue (US$ Million) & (2018-2023)
5.5.5 Quest Diagnostics Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies Metagenomics Products, Services and Solutions
5.6.4 Agilent Technologies Metagenomics Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Aperiomics
5.7.1 Aperiomics Profile
5.7.2 Aperiomics Main Business
5.7.3 Aperiomics Metagenomics Products, Services and Solutions
5.7.4 Aperiomics Metagenomics Revenue (US$ Million) & (2018-2023)
5.7.5 Aperiomics Recent Developments
5.8 Promega
5.8.1 Promega Profile
5.8.2 Promega Main Business
5.8.3 Promega Metagenomics Products, Services and Solutions
5.8.4 Promega Metagenomics Revenue (US$ Million) & (2018-2023)
5.8.5 Promega Recent Developments
5.9 Oxford Nanopore
5.9.1 Oxford Nanopore Profile
5.9.2 Oxford Nanopore Main Business
5.9.3 Oxford Nanopore Metagenomics Products, Services and Solutions
5.9.4 Oxford Nanopore Metagenomics Revenue (US$ Million) & (2018-2023)
5.9.5 Oxford Nanopore Recent Developments
5.10 Enterome SA
5.10.1 Enterome SA Profile
5.10.2 Enterome SA Main Business
5.10.3 Enterome SA Metagenomics Products, Services and Solutions
5.10.4 Enterome SA Metagenomics Revenue (US$ Million) & (2018-2023)
5.10.5 Enterome SA Recent Developments
5.11 Swift Biosciences
5.11.1 Swift Biosciences Profile
5.11.2 Swift Biosciences Main Business
5.11.3 Swift Biosciences Metagenomics Products, Services and Solutions
5.11.4 Swift Biosciences Metagenomics Revenue (US$ Million) & (2018-2023)
5.11.5 Swift Biosciences Recent Developments
6 North America
6.1 North America Metagenomics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metagenomics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metagenomics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metagenomics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metagenomics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metagenomics Market Dynamics
11.1 Metagenomics Industry Trends
11.2 Metagenomics Market Drivers
11.3 Metagenomics Market Challenges
11.4 Metagenomics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research